MustGrow Biologics Corp. faces a challenging week despite a modest uptick in price.
This week, MustGrow Biologics Corp. (MGRO.V) saw a slight price increase, closing at C$0.39 on Thursday, which reflects a 2.63% gain for the day. However, the stock is down 6.02% over the past week and significantly lower by 38.10% year-to-date.
Investor takeaway: While the recent price action shows a daily gain, the overall trend for MustGrow has been negative, with substantial declines over the last month and year. Investors should consider the company's performance metrics and market conditions before making decisions.
Advertisement
MustGrow Biologics Corp.
MGRO.V
MGRO.V
MustGrow Biologics Corp.
WealthAwesomeMarket cap
$27.46M
52W high
$0.94
52W low
$0.29
1W change
-6.02%
Beta
0.41
Analyst Price Targets
Based on analyst covering MGRO · as of Sep 30, 2026
Wall Street analysts forecast MGRO stock price to rise 543.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.51
+543.6% Upside
Previously C$2.70 on Sep 17, 2026
Current Price
C$0.39
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MGRO's historical volatility
30-Day Vol
86.2%
Annualized
90-Day Vol
78.3%
Annualized
Trend (90d)
+5.4%
Annualized drift
90d Mean
C$0.40
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.39 | C$0.29 – C$0.53 |
| 60 trading days | C$0.40 | C$0.26 – C$0.60 |
| 90 trading days | C$0.40 | C$0.24 – C$0.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock down 38.10% YTD amid challenging market conditions.
With a current market cap of about C$27.46 million, MustGrow is navigating a tough landscape in the materials sector, which is reflected in its declining stock performance.
Bull case
Analysts are optimistic about MustGrow, with an average target price of C$2.51. This suggests a potential upside of over 543%. This bullish outlook could attract long-term investors looking for growth opportunities in the materials sector.
Bear case
The company's financials reveal significant challenges, including a profit margin of -58.5% and a return on equity of -222.5%. With the stock trading well below its moving averages and a year-to-date decline, investors should proceed with caution.
Recent Price Action
Advertisement
On Thursday, MustGrow Biologics Corp. closed at C$0.39, marking a daily increase of 2.63%. Despite this positive movement, the stock has struggled overall, down 6.02% over the past week and 14.29% in the last month. Year-to-date, the stock has seen a significant decline of 38.10%, raising concerns among investors about its future trajectory.
Technical Picture
Currently, MustGrow's stock is trading below its key moving averages. The 50-day moving average stands at C$0.41, indicating a 5.0% decline from the current price, while the 200-day moving average is at C$0.52, a 25.2% difference. The stock's 52-week range is between C$0.29 and C$0.94, showing that it is trading at approximately 15% of its range. With a beta of 0.41, the stock is less volatile compared to the broader market. Recent trading volume has also been low, with only 2,250 shares exchanging hands against a 20-day average volume of 21,659 shares.
Market Sentiment
Despite the lack of recent news, analyst sentiment remains bullish on MustGrow Biologics. The average analyst target price is C$2.51, implying a significant upside potential of approximately 543.6%. This optimistic outlook may attract investors looking for growth opportunities within the materials sector, but it is essential to consider the company's current financial challenges.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
